Treatment of liver ischemia–reperfusion injury by limiting thrombospondin-1/CD47 signaling
- 30 November 2008
- journal article
- Published by Elsevier BV in Surgery
- Vol. 144 (5), 752-761
- https://doi.org/10.1016/j.surg.2008.07.009
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusionLife Sciences, 2008
- Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signalingBlood, 2008
- Blockade of Thrombospondin-1-CD47 Interactions Prevents Necrosis of Full Thickness Skin GraftsAnnals of Surgery, 2008
- Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to IschemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Increasing Survival of Ischemic Tissue by Targeting CD47Circulation Research, 2007
- The Interplay between Pro-Death and Pro-Survival Signaling Pathways in Myocardial Ischemia/Reperfusion Injury: Apoptosis Meets AutophagyCardiovascular Drugs and Therapy, 2006
- Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxationBlood, 2006
- Ischemia-reperfusion injury of the human liver during hepatic resectionJournal of Hepato-Biliary-Pancreatic Surgery, 2003
- Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liverJournal of Hepato-Biliary-Pancreatic Surgery, 2003
- Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behaviorThe Journal of cell biology, 2002